News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
109–144
Matches
654
Sources here
20
Companies here
15
Search results Stored financial headlines

Active search

654 matching headlines

Ticker or company: NSIMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

AdvanSix Inc. 2026: Revenue $421.28M, EPS $0.12— 10-Q Summary

AdvanSix Inc. reported Q2 2026 financial results with revenue of $421.28 million, a 2.7% increase year-over-year. Despite revenue growth driven by price increases, net income and diluted EPS significantly declined by 89.6% to $3.25 million and $0.12, respectively. The company highlighted strong demand in …

ASIX main company
Sharemaestro market context Price below Trend Line 52 weeks -16.2% ASIX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AdvanSix Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:ASIX) 2026-08-07

AdvanSix Inc. (NYSE: ASIX) published its Q2 2026 earnings call presentation on August 7, 2026. The company reported an EPS of $0.19, missing estimates by $0.37, and revenue of $421.28 million, missing estimates by $30.87 million. The slide deck provides details from the earnings …

ASIX main company
Sharemaestro market context Price below Trend Line 52 weeks -16.2% ASIX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

חדשות למשקיעים ב- Ensign: אם סבלתם הפסדים ב- The Ensign Group, Inc. (נאסד"ק: ENSG), אתם מוזמנים ליצור קשר עם משרד רוזן עורכי דין בנוגע לזכויותיכם

ניו יורק, Aug. 08, 2026 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, ממשיך לחקור תביעות ניירות ערך פוטנציאליות מטעם בעלי המניות של The Ensign Group, Inc. (נאסד"ק: ENSG) הנובעות מטענות לפיהן ייתכן ש- …

ENSG main company
Sharemaestro market context Price below Trend Line 52 weeks +5.5% · Next-week setup positive 63.2% ENSG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Royal Bank of Canada Sells 6,650 Shares of The Ensign Group, Inc. $ENSG

Royal Bank of Canada reduced its stake in The Ensign Group, Inc. (NASDAQ:ENSG) by 9.4% in the first quarter, selling 6,650 shares but still retaining 63,888 shares valued at approximately $12.9 million. Other institutional investors like Baillie Gifford & Co., Norges Bank, and Candriam …

ENSG main company
Sharemaestro market context Price below Trend Line 52 weeks +5.5% · Next-week setup positive 63.2% ENSG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ensign Investor News: If You Have Suffered Losses in The Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

The Rosen Law Firm is investigating potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) following a short seller report alleging the company's business model relies on inadequate patient care and gaming quality metrics, causing its stock to fall. …

ENSG main company
Sharemaestro market context Price below Trend Line 52 weeks +5.5% · Next-week setup positive 63.2% ENSG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nano Dimension Ltd. Q2 2026: Revenue $28.96M, Net loss $(6.80M) — 10-Q Summary

Nano Dimension Ltd. reported Q2 2026 financial results, showing revenue of $28.96 million, a 12% increase year-over-year, and a net loss of $(6.80) million, a significant improvement from the previous year's loss. The company's revenue growth was driven by product sales and recent acquisitions …

NNDM main company
Sharemaestro market context Price below Trend Line 52 weeks +14.8% NNDM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AdvanSix (NYSE:ASIX) Downgraded to Sell Rating by Wall Street Zen

Wall Street Zen has downgraded AdvanSix (NYSE:ASIX) from a "hold" to a "sell" rating. This downgrade comes after AdvanSix reported quarterly earnings of $0.19 per share, significantly missing the consensus estimate of $0.56, and revenue of $421.28 million, below the expected $452 million. Shares …

ASIX main company
Sharemaestro market context Price below Trend Line 52 weeks -16.2% ASIX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Intensity Therapeutics (INTS.US) will release its earnings report on August 11.

Intensity Therapeutics (INTS.US) is scheduled to release its earnings report on August 11. This announcement provides key information about the upcoming financial disclosure for the company. Investors and analysts will be anticipating the report for insights into the company's performance.

INTS main company
Sharemaestro market context Price below Trend Line 52 weeks -47.9% · Next-week setup negative 38.9% INTS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AdvanSix Releases Q2 2026 Financial Results

AdvanSix Inc. reported Q2 2026 financial results, missing Wall Street expectations with an adjusted diluted EPS of $0.19 against estimates of $0.57. The company's revenue rose 3.0% year-over-year to $421.3 million, with a positive adjusted EBITDA Margin of 7.6%. Despite headwinds in its Plant …

ASIX main company
Sharemaestro market context Price below Trend Line 52 weeks -16.2% ASIX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insight Digital Partners II Ord Shs Class A (DYOR) Stock News Today

This article provides current stock information for Insight Digital Partners II Ord Shs Class A (DYOR), noting its market performance and key financial metrics. It indicates that more news regarding the company's earnings and analyst ratings is expected soon. The page serves as a …

DYOR main company
Sharemaestro market context Trend signal active 39 weeks +1.9% DYOR stored weekly price path from 21 Nov 2025 to 14 Aug 2026

Insider Transaction: Dr. Ferruzzi Sells $155K Worth Of Sensient Technologies Shares

Dr. Ferruzzi, a Director at Sensient Technologies (NYSE: SXT), sold 1,200 shares worth $155,372, as reported in an SEC filing on August 6, 2026. The article details Sensient Technologies' financial performance, including a revenue growth of 11.55% and a gross margin of 37.4%, while …

SXT main company
Sharemaestro market context Trend signal active 52 weeks +17.8% SXT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sei Investments Co. Acquires 7,882 Shares of Insight Enterprises, Inc. $NSIT

Sei Investments Co. increased its stake in Insight Enterprises, Inc. by 17.0% during the first quarter, purchasing an additional 7,882 shares to bring its total holding to 54,294 shares valued at $3.64 million. This move coincides with strong second-quarter results for Insight Enterprises, which …

NSIT main company
Sharemaestro market context Trend signal active 52 weeks +15.2% NSIT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AdvanSix (NYSE: ASIX) swings to H1 2026 loss as costs rise

AdvanSix (NYSE: ASIX) reported a net loss of $(12,298) thousand for the first half of 2026, a significant downturn from a net income of $54,715 thousand in the prior year, despite a 4.8% increase in sales to $825,468 thousand. This loss was primarily due …

ASIX main company
Sharemaestro market context Price below Trend Line 52 weeks -16.2% ASIX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insight Molecular Diagnostics Inc. (7OC0.MU) Analyst Insights, Price Targets & Recommendations

This article provides analyst insights, price targets, and recommendations for Insight Molecular Diagnostics Inc. (7OC0.MU). It lists several instances where analysts from Lake Street and Needham have maintained a "Buy" rating for the company's stock between February 2026 and April 2025. The current stock …

IMDX main company
Sharemaestro market context Price below Trend Line 52 weeks +66.8% IMDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kaplan Fox is Investigating The Ensign Group, Inc. (ENSG) for Potential Violations of the Federal Securities Laws

Kaplan Fox & Kilsheimer LLP is investigating The Ensign Group, Inc. (ENSG) for potential securities violations following a Hunterbrook Media report alleging inadequate patient care and data manipulation. The report, titled "Ensign: The Nursing Home Empire Built On Fatal Neglect," caused Ensign's stock to …

ENSG main company
Sharemaestro market context Price below Trend Line 52 weeks +5.5% · Next-week setup positive 63.2% ENSG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

21,400 Shares in The Ensign Group, Inc. $ENSG Bought by Renaissance Technologies LLC

Renaissance Technologies LLC acquired a new stake of 21,400 shares in The Ensign Group, Inc. (ENSG) during the first quarter, valued at approximately $4.3 million. This purchase contributes to the 96.12% institutional ownership of ENSG, although some directors recently sold shares under pre-arranged plans. …

ENSG main company
Sharemaestro market context Price below Trend Line 52 weeks +5.5% · Next-week setup positive 63.2% ENSG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insight Digital Partners II Ord Shs Class A (DYOR) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Insight Digital Partners II Ord Shs Class A (DYOR), detailing future EPS and revenue growth estimates. It includes current stock data such as market capitalization and P/E ratio, alongside a peer comparison for other investment holding companies. …

DYOR main company
Sharemaestro market context Trend signal active 39 weeks +1.9% DYOR stored weekly price path from 21 Nov 2025 to 14 Aug 2026

Form 8K AdvanSix Inc For: 7 August By Investing.com

This article announces that AdvanSix Inc. has filed a Form 8K on August 7th. A Form 8K is a crucial document that public companies file with the SEC to announce major events that shareholders should know about. The article itself does not provide further …

ASIX main company
Sharemaestro market context Price below Trend Line 52 weeks -16.2% ASIX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context